Welcome to LookChem.com Sign In|Join Free
  • or
Fosfluconazole is a phosphate prodrug of fluconazole, specifically designed to improve the water solubility and reduce the infusion volume required for intravenous administration. It was launched in Japan for the treatment of candidiasis and cryptococcosis infections. Fluconazole, the active component, is a triazole antifungal agent that selectively inhibits fungal cytochrome P450 sterol C-14 alpha-demethylation, making it effective against serious systemic fungal infections.

194798-83-9

Post Buying Request

194798-83-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

194798-83-9 Usage

Uses

Used in Pharmaceutical Industry:
Fosfluconazole is used as an intravenous injection for the treatment of candidiasis and cryptococcosis infections. It offers a solution to the high-volume infusion issue associated with fluconazole by providing approximately 40-fold higher water solubility, allowing for a substantial reduction in infusion volume. This makes it particularly beneficial for critically ill patients where fluid overload must be avoided.
Used in Antifungal Treatments:
Fosfluconazole is used as an antifungal agent, rapidly hydrolyzed to fluconazole by phosphatase enzymes in vivo. It exhibits similar efficacy to fluconazole in experimental models of fungal disease, providing an effective treatment option for patients with deep-seated mycosis due to Candida or Cryptococcus.
Brand Name:
The brand name for fosfluconazole is Prodif.

Originator

Pfizer (Japan)

Check Digit Verification of cas no

The CAS Registry Mumber 194798-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,7,9 and 8 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 194798-83:
(8*1)+(7*9)+(6*4)+(5*7)+(4*9)+(3*8)+(2*8)+(1*3)=209
209 % 10 = 9
So 194798-83-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H13F2N6O4P/c14-10-1-2-11(12(15)3-10)13(25-26(22,23)24,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9H,4-5H2,(H2,22,23,24)

194798-83-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name [2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-yl] dihydrogen phosphate

1.2 Other means of identification

Product number -
Other names UNII-3JIJ299EWH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:194798-83-9 SDS

194798-83-9Downstream Products

194798-83-9Relevant academic research and scientific papers

Preparation method of fosfluconazole

-

Paragraph 0063; 0064-0084, (2020/06/17)

The invention provides a preparation method of fosfluconazole. The method comprises the following steps: preparing fluconazole dichlorophosphate: under the protection of nitrogen, controlling the temperature to be-10 DEG C to 0 DEG C, slowly dropwise adding phosphorus oxychloride into a dichloromethane solution of triethylamine, maintaining the temperature to be-10 DEG C to 0 DEG C, performing stirring for 1 hour, slowly dropwise adding a dichloromethane solution of fluconazole, and monitoring the completion of the reaction by TLC; maintaining temperature between-10 DEG C and 0 DEG C, adding water and stirring for 30 minutes, adding inorganic base until the pH value of the water phase is at least 8; and performing standing stratification, separating out the fluconazole, wherein the organicphase contains the fluconazole dichlorophosphate, the fluconazole is prepared through the fluconazole-fluconazole dichlorophosphate-fluconazole dibenzyl phosphate-fosfluconazole ammonium salt-fosfluconazole process, the yield is increased, all intermediates are controllably prepared, the raw materials can be recycled, and raw material waste and organic waste pollution are reduced.

Compound and preparation method and application thereof

-

Paragraph 0041; 0042; 0043; 0044; 0045; 0046, (2017/03/22)

The invention discloses a compound of 2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4,-triazole-1-yl)-2-propyl di-tert-butylphosphate, a preparation method thereof, and an application of 2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4,-triazole-1-yl)-2-propyl di-tert-butylphosphate to prepare 2,4-difluoro-alpha, alpha-di(1H-1,2,4,-triazole-1-yl methyl) benzyl alcohol dihydrogen phosphate. The method is mild in reaction conditions and can well protect the environment.

Triazole derivatives useful in therapy

-

, (2008/06/13)

The invention provides compounds of formula 1, R1—OP(O)(OH)2??I wherein R1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically accepta

The discovery and process development of a commercial route to the water soluble prodrug, fosfluconazole

Bentley, Arthur,Butters, Michael,Green, Stuart P.,Learmonth, William J.,MacRae, Julie A.,Morland, Matthew C.,O'Connor, Garry,Skuse, Joanne

, p. 109 - 112 (2013/09/06)

A case history detailing the rationale behind the discovery of 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazole-1-yl)-2-propyl dihydrogen phosphate, fosfluconazole (2), a water-soluble prodrug of Diflucan, and the subsequent development of a commercial route is presented. Particular items to note are (i) that this compound was discovered in the Chemical Research and Development Department, hence Chemical Research and Development can play a key role in prodrug discovery, (ii) the strategy behind the selection of phosphate ester promoiety, by phosphorylation of a sterically hindered tertiary alcohol, (iii) the development of the initial route to remove thermally hazardous reagents and to improve processing to allow scale-up, and (iv) the identification and development of the proposed commercial process.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 194798-83-9